1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow LN-145 + pembrolizumab: new trials by email Literature Review of LN-145 + pembrolizumab trials Research Report on LN-145 + pembrolizumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma LN-145, LN-145 + pembrolizumab - Cervical Carcinoma | Phase 2 | Terminated | Iovance Biotherapeutics, Inc. | 210 | 2017-06-22 | 2026-09-25 |
Uterine Cervical Neoplasms (1)
Iovance Biotherapeutics, Inc. (1)
France (1) · Germany (1) · Italy (1) · Netherlands (1) · Spain (1) · Switzerland (1) · United Kingdom (1) · United States (1)